Bristol-Myers Squibb Company
Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists

Abstract:

The disclosure relates to compounds of formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, and related diseases. ##STR00001##